139 related articles for article (PubMed ID: 34577897)
1.
Mockute R; Vilkeviciute A; Balciuniene VJ; Zemaitiene R; Liutkeviciene R
Medicina (Kaunas); 2021 Sep; 57(9):. PubMed ID: 34577897
[No Abstract] [Full Text] [Related]
2. CYP4F2 (rs2108622) Gene Polymorphism Association with Age-Related Macular Degeneration.
Sakiene R; Vilkeviciute A; Kriauciuniene L; Balciuniene VJ; Buteikiene D; Miniauskiene G; Liutkeviciene R
Adv Med; 2016; 2016():3917916. PubMed ID: 27652291
[TBL] [Abstract][Full Text] [Related]
3. Genetic Variants of Complement Factor H Y402H (rs1061170), C2 R102G (rs2230199), and C3 E318D (rs9332739) and Response to Intravitreal Anti-VEGF Treatment in Patients with Exudative Age-Related Macular Degeneration.
Kubicka-Trząska A; Żuber-Łaskawiec K; Dziedzina S; Sanak M; Romanowska-Dixon B; Karska-Basta I
Medicina (Kaunas); 2022 May; 58(5):. PubMed ID: 35630075
[No Abstract] [Full Text] [Related]
4. Photodynamic therapy in VEGF inhibition non-responders-Pharmacogenetic study in age-related macular degeneration assessed with swept-source optical coherence tomography.
Teper SJ; Nowinska A; Pilat J; Wylegala E
Photodiagnosis Photodyn Ther; 2016 Mar; 13():108-113. PubMed ID: 26780119
[TBL] [Abstract][Full Text] [Related]
5. ABCA1 rs1883025 polymorphism and risk of age-related macular degeneration.
Wang Y; Wang M; Han Y; Zhang R; Ma L
Graefes Arch Clin Exp Ophthalmol; 2016 Feb; 254(2):323-32. PubMed ID: 26608582
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the association between CFH Y402H polymorphism and response to intravitreal ranibizumab in patients with neovascular age-related macular degeneration (nAMD).
Mohamad NA; Ramachandran V; Ismail P; Mohd Isa H; Chan YM; Ngah NF; Md Bakri N; Ching SM; Hoo FK; Wan Sulaiman WA; Inche Mat LN; Hazmi Mohamed M
Bosn J Basic Med Sci; 2018 Aug; 18(3):260-267. PubMed ID: 29579408
[TBL] [Abstract][Full Text] [Related]
7. Association of the CFH Y402H Polymorphism with the 1-Year Response of Exudative AMD to Intravitreal Anti-VEGF Treatment in the Brazilian Population.
Medina FMC; Motta AALD; Takahashi WY; Carricondo PC; Motta MMDS; Melo MB; Vasconcellos JPC
Ophthalmic Res; 2019; 61(3):168-173. PubMed ID: 28641277
[TBL] [Abstract][Full Text] [Related]
8. Effects of vitreomacular adhesion on anti-vascular endothelial growth factor treatment for exudative age-related macular degeneration.
Lee SJ; Koh HJ
Ophthalmology; 2011 Jan; 118(1):101-10. PubMed ID: 20678805
[TBL] [Abstract][Full Text] [Related]
9. The Role of SNPs in
Vilkeviciute A; Bastikaityte N; Mockute R; Cebatoriene D; Kriauciuniene L; Balciuniene J; Zemaitiene R; Liutkeviciene R
In Vivo; 2020; 34(5):2443-2451. PubMed ID: 32871771
[TBL] [Abstract][Full Text] [Related]
10. [Association between Y402H, E318D and R102G polymorphisms of complement proteins genes and the response to intravitreal anti-VEGF treatment in patients with neovascular age-related macular degeneration].
Kubicka-Trząska A; Karska-Basta I; Kobylarz J; Dziedzina S; Sanak M; Romanowska-Dixon B
Klin Oczna; 2016; 118(2):114-21. PubMed ID: 29912491
[TBL] [Abstract][Full Text] [Related]
11. Non-responsiveness and tachyphylaxis to anti-vascular endothelial growth factor treatment in naive patients with exudative age-related macular degeneration.
Zuber-Laskawiec K; Kubicka-Trzaska A; Karska-Basta I; Pociej-Marciak W; Romanowska-Dixon B
J Physiol Pharmacol; 2019 Oct; 70(5):. PubMed ID: 32009630
[TBL] [Abstract][Full Text] [Related]
12. VITREOMACULAR TRACTION AFFECTS ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT OUTCOMES FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION.
Krishnan R; Arora R; De Salvo G; Stinghe A; Severn PS; Pal B; Goverdhan S
Retina; 2015 Sep; 35(9):1750-6. PubMed ID: 26237240
[TBL] [Abstract][Full Text] [Related]
13. Variants in the VEGFA gene and treatment outcome after anti-VEGF treatment for neovascular age-related macular degeneration.
Abedi F; Wickremasinghe S; Richardson AJ; Makalic E; Schmidt DF; Sandhu SS; Baird PN; Guymer RH
Ophthalmology; 2013 Jan; 120(1):115-21. PubMed ID: 23149126
[TBL] [Abstract][Full Text] [Related]
14. Coronary artery disease, its associations with ocular, genetic and blood lipid parameters.
Matulevičiūtė I; Tatarūnas V; Skipskis V; Čiapienė I; Veikutienė A; Lesauskaitė V; Dobilienė O; Žaliūnienė D
Eye (Lond); 2024 Feb; 38(2):372-379. PubMed ID: 37587376
[TBL] [Abstract][Full Text] [Related]
15. VEGF gene polymorphism and response to intravitreal ranibizumab in neovascular age-related macular degeneration.
Veloso CE; de Almeida LN; Recchia FM; Pelayes D; Nehemy MB
Ophthalmic Res; 2014; 51(1):1-8. PubMed ID: 24157918
[TBL] [Abstract][Full Text] [Related]
16. Role of vascular endothelial growth factor polymorphisms in the treatment success in patients with wet age-related macular degeneration.
Boltz A; Ruiß M; Jonas JB; Tao Y; Rensch F; Weger M; Garhöfer G; Frantal S; El-Shabrawi Y; Schmetterer L
Ophthalmology; 2012 Aug; 119(8):1615-20. PubMed ID: 22521084
[TBL] [Abstract][Full Text] [Related]
17. CETP Gene may be Associated with Advanced Age-Related Macular Degeneration in the Chinese Population.
Wang D; Zhou J; Hou X; Nguyen DH; Cao G; Li G; Qiu G; Zhang K; Zhang M; Su Z
Ophthalmic Genet; 2015; 36(4):303-8. PubMed ID: 24498989
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetic Association between Allelic Variants of the Autophagy-Related Genes and Anti-Vascular Endothelial Growth Factor Treatment Response in Neovascular Age-Related Macular Degeneration.
Kozhevnikova OS; Fursova AZ; Derbeneva AS; Nikulich IF; Devyatkin VA; Kolosova NG
Biomedicines; 2023 Nov; 11(11):. PubMed ID: 38002079
[TBL] [Abstract][Full Text] [Related]
19. Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to intravitreal bevacizumab.
Brantley MA; Fang AM; King JM; Tewari A; Kymes SM; Shiels A
Ophthalmology; 2007 Dec; 114(12):2168-73. PubMed ID: 18054635
[TBL] [Abstract][Full Text] [Related]
20. Association of genetic polymorphisms with response to bevacizumab for neovascular age-related macular degeneration in the Chinese population.
Tian J; Qin X; Fang K; Chen Q; Hou J; Li J; Yu W; Chen D; Hu Y; Li X
Pharmacogenomics; 2012 May; 13(7):779-87. PubMed ID: 22594510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
